ArticleMikrochimica acta2018
Fluorometric determination of zinc(II) by using DNAzyme-modified magnetic microbeads.
Article in Mikrochimica acta, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Peptide Self-Assembled Nanocarriers for Cancer Drug Delivery.The journal of physical chemistry. B · 2023Review
- Electrochemical impedance biosensor array based on DNAzyme-functionalized single-walled carbon nanotubes using Gaussian process regression for Cu(II) and Hg(II) determination.Mikrochimica acta · 2020Article
- Nanoparticle- and microparticle-based luminescence imaging of chemical species and temperature in aquatic systems: a review.Mikrochimica acta · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
A fluorometric assay for zinc ion is described that relies (a) on the use of an isothermal cycle to amplify the fluorescence signal, and (b) of magnetic beads (MBs) to completely remove unreacted DNA detection probes. Biotin and fluorophore-labeled substrate (Zn-Sub) strands acting as detection probes were first assembled on MBs. Next, Zn(II)-specific DNAzyme (Zn-Enz) strands were hybridized with the Zn-Sub strands. In the presence of Zn(II), the Zn-Sub strands are cleaved. This results in the release of the shorter DNA fragments (containing fluorescent label) and in the dissociation of Zn-Enz strands. The dissociated Zn-Enz strands then hybridize with the residual Zn-Sub strands and cleave them in a similar fashion. This leads to a target recycling amplification mechanism and in a cumulative signal amplification process. A strongly amplified signal is thus obtained in the presence of Zn(II). The use of MBs warrants that unreacted Zn-Sub strands can be magnetically separated from the solution. The method has a detection limit as low as 33 fM at a signal-to-noise ratio of 3 and a linear response in the 100 fM to 11 nM Zn(II) concentration range. It was applied to the determination of Zn(II) in spiked tap water and seawater samples, and the results compared well with data obtained by ICP-MS analysis. The method was also applied to the determination of Zn(II) in infant milk powder and breast milk. Graphical abstract Magnetic beads (MBs) carrying fluorescein-labeled substrate (Zn-Sub) strands were hybridized with Zn(II)-specific DNAzyme (Zn-Enz) and cleaved in the presence of Zn(II). After recycling, the unreacted Zn-Sub strands were removed with MBs and the released fluorescein tags are measured.
Indexed as
Identifiers
30187135What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.